RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to decode therapeutically significant protein interfaces, revolutionizing the discovery of antibody-based drugs. RubrYc Therapeutics using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies. Inspired byrecent advancements in molecular library synthesis, massively parallel screening and computing, they are forging a new path for information-driven discovery of therapeutic antibodies.